Roles for negative cell regulator 14-3-3σ in control of MDM2 activities

被引:46
|
作者
Yang, H-Y
Wen, Y-Y
Lin, Y-I
Pham, L.
Su, C-H
Yang, H.
Chen, J.
Lee, M-H
机构
[1] Univ Texas, MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Univ Texas, Grad Sch Biomed Sci, Program Gen & Dev, Houston, TX USA
[3] Univ Texas, Grad Sch Biomed Sci, Program Canc Biol, Houston, TX USA
[4] Zhongshan Univ, Dept Pathophysiol, Guangzhou, Peoples R China
[5] Univ S Florida, H Lee Moffitt Canc Ctr, Tampa, FL 33682 USA
关键词
MDM2; 14-3-3; NEDDylation; p53; RB;
D O I
10.1038/sj.onc.1210540
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The 14-3-3 sigma, upregulated by p53 in response to DNA damage, can have a positive-feedback impact driving p53 activities and is a human cancer epithelial marker downregulated in various tumors. However, the precise roles of 14-3-3 sigma during tumorigenesis are not well characterized. Here, we show that 14-3-3 sigma is a critical regulator of murine double minute oncogene (MDM2). 14-3-3 sigma interacts with MDM2 at the RING domain. The C-terminal region of 14-3-3 sigma binds to MDM2 very efficiently. Importantly, 14-3-3 sigma overexpression leads to destabilization of MDM2 through enhancing MDM2 self-ubiquitination and accelerating turnover rate. Conversely, loss of 14-3-3 sigma results in a significant increase in MDM2 protein. Moreover, live-cell images indicated that 14-3-3 sigma can affect the location of MDM2 from the nucleus to the cytoplasm, and that MDM2-mediated cytoplasmic localization of p53 can be reversed by the presence of 14-3-3 sigma. Significantly, we further showed that 14-3-3 sigma causes MDM2 downregulation, thereby stabilizing p53 and inhibiting tumor growth in animal tumors. Also, 14-3-3 sigma blocks MDM2-mediated retinoblastoma degradation and p53 NEDDylation. Our results provide evidence that 14-3-3 sigma is a pivotal MDM2 regulator involved in blocking a variety of activities of MDM2.
引用
收藏
页码:7355 / 7362
页数:8
相关论文
共 50 条
  • [1] Roles for negative cell regulator 14-3-3σ in control of MDM2 activities
    H-Y Yang
    Y-Y Wen
    Y-l Lin
    L Pham
    C-H Su
    H Yang
    J Chen
    M-H Lee
    Oncogene, 2007, 26 : 7355 - 7362
  • [2] CARPs enhance p53 turnover by degrading 14-3-3σ and stabilizing MDM2
    Yang, Wensheng
    Dicker, David T.
    Chen, Jiandong
    El-Deiry, Wafik S.
    CELL CYCLE, 2008, 7 (05) : 670 - 682
  • [3] MDM2 induces EMT via the B-Raf signaling pathway through 14-3-3
    Ou, Mengting
    Xu, Xichao
    Chen, Ying
    Li, Li
    Zhang, Lu
    Liao, Yi
    Sun, Weichao
    Quach, Christine
    Feng, Jianguo
    Tang, Liling
    ONCOLOGY REPORTS, 2021, 46 (01)
  • [4] Mdm2: A regulator of cell growth and death
    Vargas, DA
    Takahashi, S
    Ronai, Z
    ADVANCES IN CANCER RESEARCH, VOL 89, 2003, 89 : 1 - 34
  • [5] Characterizing the protein-protein interaction between MDM2 and 14-3-3σ; proof of concept for small molecule stabilization
    Ward, Jake A.
    Romartinez-Alonso, Beatriz
    Kay, Danielle F.
    Bellamy-Carter, Jeddidiah
    Thurairajah, Bethany
    Basran, Jaswir
    Kwon, Hanna
    Leney, Aneika C.
    Macip, Salvador
    Roversi, Pietro
    Muskett, Frederick W.
    Doveston, Richard G.
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2024, 300 (02)
  • [6] ZLM-7 Blocks Breast Cancer Progression by Inhibiting MDM2 via Upregulation of 14-3-3 Sigma
    Wen, Min
    Zou, Zi-Zheng
    Luo, Tiao
    Li, Xuan
    Liu, Su-You
    Li, Ji-Jia
    Luo, Zhi-Yong
    PHARMACEUTICALS, 2022, 15 (07)
  • [7] Roles for CSN5 in control of p53/MDM2 activities
    Zhang, Xiao-Chun
    Chen, Jian
    Su, Chun-Hui
    Yang, Heng-Yin
    Lee, Mong-Hong
    JOURNAL OF CELLULAR BIOCHEMISTRY, 2008, 103 (04) : 1219 - 1230
  • [8] 浸润性乳腺癌组织中14-3-3σ和Mdm2蛋白的表达
    朱安峰
    当代医学, 2012, 18 (34) : 31 - 31
  • [9] The Mdm2 oncoprotein interacts with the cell fate regulator numb
    Juven-Gershon, T
    Shifman, O
    Unger, T
    Elkeles, A
    Haupt, Y
    Oren, M
    MOLECULAR AND CELLULAR BIOLOGY, 1998, 18 (07) : 3974 - 3982
  • [10] Distinct roles of Mdm2 and Mdm4 in red cell production
    Maetens, Marion
    Doumont, Gilles
    De Clercq, Sarah
    Francoz, Sarah
    Froment, Pascal
    Bellefroid, Eric
    Klingmuller, Ursula
    Lozano, Guillermina
    Marine, Jean-Christophe
    BLOOD, 2007, 109 (06) : 2630 - 2633